Keep Me Updated

Sign up for the latest updates as we advance precision genetic medicines as potential treatments for myotonic dystrophy type 1 (DM1), Huntington’s disease (HD), and cancers driven by KRAS G12D and G12V mutations.

* indicates required



I’m interested in receiving news on: